Universal Ibogaine provides update on prior application for Management Cease Trade Order

2023-12-11T14:02:41-08:00December 1st, 2023|Universal Ibogaine News|

Calgary, AB - TheNewswire - December 1, 2023 - Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises of the following update and revision to its prior news release which was issued on November 20, 2023. At that time, UI had advised that it has made an application to the [...]

Universal Ibogaine advises of application for Management Cease Trade Order

2023-11-24T20:54:00-08:00November 24th, 2023|Universal Ibogaine News|

Calgary, AB – November 20, 2023 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has made an application to the Alberta Securities Commission (as Principal Regulator) and the British Columbia Securities Commission, to approve a temporary management case trade order (“MCTO”) under National [...]

Universal Ibogaine Advises of Board Member Changes

2023-10-16T14:08:46-07:00October 12th, 2023|Universal Ibogaine News|

Calgary, AB - TheNewswire - October 12, 2023 - Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises of the following changes to its Board of Directors, effective October 11, 2023: UI has appointed two new members to serve on the Company’s Board of Directors (the “Board”) to replace two [...]

Universal Ibogaine Engages Mike “Zappy” Zapolin as a Strategic Advisor

2023-10-12T11:49:03-07:00October 4th, 2023|Universal Ibogaine News|

Calgary, AB – TheNewswire - October 4, 2023 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to advise that it has engaged and retained Mike “Zappy” Zapolin as a strategic and business development advisor. Zappy Zapolin is a well-known USA based futurist, entrepreneur, and award-winning filmmaker [...]

Universal Ibogaine Provides Corporate Update on Belize Property and Notice of Resignation of Auditors

2023-09-07T14:17:08-07:00September 7th, 2023|Universal Ibogaine News|

Calgary, AB - TheNewswire - September 6, 2023 - Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following updates: UI continues efforts to seek to sell its 20 acre undeveloped Belize island property (see prior news release of June 7, 2023) and a further update will be provided [...]

Universal Ibogaine Advises Of Update On The Status Of Proposed Sale Of Belize Island Property

2023-06-07T11:24:16-07:00June 7th, 2023|Universal Ibogaine News|

Calgary, AB – TheNewswire - June 7, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it will not be closing its previously announced (see News Release of March 30, 2023) agreement to sell its 20-acre undeveloped island property located in Belize (the “ Property ”) for USD [...]

Universal Ibogaine Announces Offering Of Common Shares

2023-05-19T11:46:03-07:00May 19th, 2023|Universal Ibogaine News|

Calgary, AB – TheNewswire - May 19, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is undertaking an offering of up to 66,666,667 share “ Units ” at a price of $0.03 per Unit (the “ Offering ”) for proceeds of up to $2,000,000.  Each Unit will consist [...]

Universal Ibogaine Announces Changes to Board of Directors and Advisory Board

2023-05-09T11:47:45-07:00May 9th, 2023|Universal Ibogaine News|

Calgary, AB – May 9, 2023 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises of the departure of two members of its Board of Directors (the “Board”). Dr. Alberto Sola Agullo has decided to resign from the Board in order to focus his time on [...]

Universal Ibogaine Announces Closing of Offering of Convertible Debt Securities

2023-04-14T08:31:12-07:00April 14th, 2023|Universal Ibogaine News|

Calgary, AB – TheNewswire - April 13, 2023 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has processed a closing of $180,000 under its previously announced (see News Release of March 16, 2023) offering of convertible debt securities (the “Offering”).  The Offering consisted of “Secured [...]

Universal Ibogaine Announces Agreement for Sale of Belize Property

2023-03-30T11:07:00-07:00March 30th, 2023|Universal Ibogaine News|

Calgary, AB – TheNewswire - March 30, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has reached an agreement (the “ Offer ”) to sell its 20-acre undeveloped island property located in Belize (the “ Property ”) for USD 1,300,000.  A summary of the terms of the sale [...]

Go to Top